Monotherapy with darunavir/ritonavir is effective and safe in clinical practice

被引：9

作者：

Pasquau, Juan ^{[1
]}

Lopez-Cortes, Luis ^{[2
]}

Isabel Mayorga, Maria ^{[3
]}

Viciana, Pompeyo ^{[2
]}

del Mar Arenas, Maria ^{[1
]}

Jose Rios, Maria ^{[4
]}

Hernandez-Quero, Jose ^{[5
]}

Castano, Manuel ^{[3
]}

Dolores Merino, Maria ^{[6
]}

Marquez, Manuel ^{[7
]}

Vergara, Antonio ^{[8
]}

Terron, Alberto ^{[9
]}

Tellez, Francisco ^{[10
]}

Hidalgo-Tenorio, Carmen ^{[1
]}

机构：

[1] Hosp Virgen de las Nieves, Granada, Spain

[2] Hosp Virgen del Rocio, Seville, Spain

[3] Hosp Carlos Haya, Malaga, Spain

[4] Hosp Virgen de Macarena, Seville, Spain

[5] Hosp Clinco San Cecilio, Granada, Spain

[6] Complejo Hosp Huelva, Huelva, Spain

[7] Hosp Virgen de la Victoria, Malaga, Spain

[8] Hosp Puerto Real, Cadiz, Spain

[9] Hosp Jerez, Jerez de la Frontera, Spain

[10] Hosp La Linea, La Linea, Cadiz, Spain

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2014年 / 17卷

关键词：

D O I：

10.7448/IAS.17.4.19813

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P281

引用

页码：196 / 197

页数：2

共 50 条

[1] Darunavir/ritonavir monotherapy in clinical practice
Parienti, Jean-Jacques
AIDS, 2011, 25 (01) : 119 - 119
[2] Virological efficacy of darunavir/ritonavir monotherapy in clinical practice
Brown, G.
Scott, C.
Teague, A.
Bower, M.
Gazzard, B.
Nelson, M.
HIV MEDICINE, 2010, 11 : 24 - 24
[3] Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice
Santos, Jose R.
Curran, Adrian
Navarro-Mercade, Jordi
Ampuero, Mario F.
Pelaez, Pablo
Perez-Alvarez, Nuria
Clotet, Bonaventura
Paredes, Roger
Molto, Jose
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (06) : 513 - 518
[4] In monotherapy, darunavir/cobicistat demonstrates equivalence to darunavir/ritonavir, and in selected patients is as effective as bitherapies or triple therapies
Pasquau, Juan
Garcia-Vallecillos, Coral
Teresa Cruces-Moreno, Maria
Elizabeth de Jesus, Samantha
Fatoul del Pino, Georgette
Hidalgo-Tenorio, Carmen
Vinuesa-Garcia, David
Angel Lopez-Ruz, Miguel
Hernandez-Quero, Jose
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[5] Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
Santos, Jose R.
Molto, Jose
Llibre, Josep M.
Negredo, Eugenia
Bravo, Isabel
Ornelas, Arelly
Clotet, Bonaventura
Paredes, Roger
PLOS ONE, 2012, 7 (05):
[6] Outcomes of protease inhibitor Darunavir/Ritonavir (DRV/r) monotherapy in a clinical setting
Castles, R.
Pacho, C.
Swan, J.
Sonecha, S.
Nelson, M.
HIV MEDICINE, 2012, 13 : 70 - 70
[7] SIMPLIFICATION OF THE ANTIRETROVIRAL TREATMENT WITH DARUNAVIR BOOSTED WITH RITONAVIR IN MONOTHERAPY
Rivas Luis, Gonzalez
Gomez Ernesto, Sanchez
del Moral Raquel, Sanchez
Saiz Salvador, Grutzmancher
de la Llave Emilio, Pujol
ATENCION FARMACEUTICA, 2011, 13 (06): : 370 - +
[8] Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial
Santos, Jose R.
Llibre, Josep M.
Bravo, Isabel
Garcia-Rosado, Dacil
Paz Canadas, Mari
Perez-Alvarez, Nuria
Paredes, Roger
Clotet, Bonaventura
Molto, Jose
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (05) : 452 - 455
[9] Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients
Gianotti, Nicola
Cozzi-Lepri, Alessandro
Antinori, Andrea
Castagna, Antonella
De Luca, Andrea
Celesia, Benedetto Maurizio
Galli, Massimo
Mussini, Cristina
Pinnetti, Carmela
Spagnuolo, Vincenzo
Monforte, Antonella d'Arminio
Ceccherini-Silberstein, Francesca
Andreoni, Massimo
PLOS ONE, 2017, 12 (02):
[10] Budget impact analysis of switch to darunavir/ritonavir monotherapy in Greece
Lazanas, M.
Hill, A.
Sawyer, A.
Paparouni, K.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 69 - 69

← 1 2 3 4 5 →